Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety and effectiveness of Ranolazine,
and how well it is tolerated in patients with Amyotrophic Lateral Sclerosis (ALS). Ranolazine
is an FDA approved drug that is used for decreasing chest pain.